Teladoc Health, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -279.2% | – | -2.4% | +84.9% | -16.1% | +0.2% | |
| – | +109.6% | +70.1% | +130.9% | +86.4% | +26.3% | +73.7% | +181.3% | +21.9% | +30.2% | +9.8% | -5.2% | |
| – | +476.9% | +151.2% | +296.2% | +43.0% | +52.4% | +612.9% | -36.4% | -28.0% | -7.5% | -27.6% | -44.9% | |
| – | +154.5% | +209.0% | +74.4% | +19.5% | +52.9% | +583.3% | +13.4% | +2,906.9% | – | – | – | |
| – | -141.7% | – | – | -256.9% | – | – | – | – | – | -411.9% | – | |
| – | +350.8% | -56.4% | +61.6% | +52.4% | +29.7% | +138.9% | -67.2% | +93.1% | +848.7% | -93.1% | -17.6% | |
| – | +594.6% | – | -1,814.9% | -42.6% | – | -2,462.7% | -87.7% | +129.8% | -6.8% | -20.7% | +114.4% | |
| – | – | – | – | – | – | -1.1% | – | – | – | – | – | |
| – | – | -98.3% | +9,688.9% | +34.3% | -100.4% | +1,601.9% | – | -70.9% | -102.2% | – | – | |
| – | -97.6% | +3,708.5% | +1,044.3% | +36.9% | +204.8% | +13.5% | -100.1% | +244.3% | -100.0% | – | – | |
| – | +133.8% | -87.4% | +2,208.1% | +35.8% | -94.6% | +2,348.1% | -95.2% | -84.1% | +67.1% | -23.4% | -6,736.8% | |
| – | -80.0% | -158.5% | – | – | -76.3% | +142.3% | -26.9% | -84.6% | +731.9% | -15.0% | -396.2% | |
| – | – | – | – | – | – | -519.4% | – | -6.8% | +12.1% | +46.1% | +0.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.